Suppliers / Jiangxi Nuclear Industry Reyphon Bio-Chemical

Jiangxi Nuclear Industry Reyphon Bio-Chemical

China Updated 9 July 2026

Jiangxi Nuclear Industry Reyphon Bio-Chemical is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Polymyxin B US FDA 1

Also appears on these molecule pages

Polymyxin B API

Questions about Jiangxi Nuclear Industry Reyphon Bio-Chemical

Does Jiangxi Nuclear Industry Reyphon Bio-Chemical hold a US DMF or a CEP?
Jiangxi Nuclear Industry Reyphon Bio-Chemical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangxi Nuclear Industry Reyphon Bio-Chemical make?
1 molecule is on record against Jiangxi Nuclear Industry Reyphon Bio-Chemical, including Polymyxin B. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangxi Nuclear Industry Reyphon Bio-Chemical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Livzon Group Fuzhou Fuxing Pharmaceutical shares 1 molecule Xellia Pharmaceuticals shares 1 molecule Hangzhou Zhongmei Huadong Pharmaceutical shares 1 molecule Chengdu Yacht Biotechnology shares 1 molecule Hebei Shengxue Dacheng Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability